MMU banner 1

Category: COVID19

#ICEM22 Melbourne – Day 1

Natalie May reviews day 1 of the #ICEM22 conference in Melbourne, Australia @stemlyns @_nmay #FOAMed @icem2022 @ifempreselect @ifem2

Thinking pragmatically about capacity

Editor: This is a guest post by Simon Horne. It is likely one of the last posts from Virchester before the festive season properly commences. Take care and stay safe. Happy holidays everyone! Three jobs,

JC: Non-invasive ventilation for COVID 19 patients. The Recovery RS trial. St Emlyn’s

I remember back at the beginning of the pandemic when we were seeing lots of patients arriving in the ED in extremis. The now familiar picture of the deeply hypoxic patient with terrible chest X-rays

EMTA Survey 2020: The good, the bad and the ugly

Co-authored with Dan Darbyshire (@dsdarbyshire) Training and practicing in emergency medicine has been hard the last 18 months. The 2020 EMTA survey tells us where things are not working and where things could be better

JC: Thromboprophylaxis for the non ICU hospitalised COVID-19 patient. St Emlyn’s

Back in March we reported on a pre-print trial of thromboprophylaxis of ICU patients. The results suggested that there was no benefit for therapeutic dose anticoagulation in COVID19 as a prophylactic strategy for critically ill patients with COVID19. This

REGN monoclonal antibodies work in selected hospitalised COVID-19 patients. St Emlyn’s

We’ve reported on the RECOVERY trial several times already on the blog. It stands out as the most important trial of therapeutics in hospitalised patients with COVID19. In the last month the RECOVERY trial has

JC: Aspirin is not effective for hospitalised COVID19 patients. St Emlyn’s

We’ve reported on the RECOVERY trial several times already on the blog. It stands out as the most important trial of therapeutics in hospitalised patients with COVID19. This week the RECOVERY trial has released the

March 2021 Podcast Round Up (episode 187). St Emlyn’s

A discussion about all the latest from the St Emlyn’s blog, including a hot off the press article about vaccine induced thrombocytopenic thrombosis and the new FRCEM revision guide.  Simon and Iain also talk about the latest results from

VITT

Post-vaccine headache in the Emergency Department: what you need to know. St Emlyn’s

I am sure you all saw the recent MHRA press release and guidance, discussing the issue of a possible link between the AstraZeneca COVID19 vaccine and a rare type of thrombotic condition of Vaccine induced

thromboprophylaxis

JC: Thromboprophylaxis on the ICU for COVID-19 patients. St Emlyn’s

The prevention of venous thromboembolism (VTE) has been a real concern in the management of hospitalised patients with COVID-19. We have previously discussed the role of prophylactic anticoagulation (thromboprophylaxis) for these patients as it was